EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The continuing evolution of antibiotic resistance in Neisseria gonorrhoeae : past, present and future threats to effective treatment

Helen Fifer iD, Alan Johnson

Journal of Antimicrobial Chemotherapy · 02.05.2025 · 80 (5) · 1213-1219

DOI: 10.1093/jac/dkaf109 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Antimicrobial Chemotherapy, online erschienen am 10.04.2025. Verfasst von Helen Fifer und 1 weiteren Autor:innen. Beteiligte Einrichtung: Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London NW9 5EQ, UK. Hauptthemen laut MEDLINE: Neisseria gonorrhoeae, Gonorrhea, Anti-Bacterial Agents, Drug Resistance, Bacterial. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 79 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gonorrhoea constitutes a global public health threat. Although a range of antibiotics have been available to treat gonococcal infections for more than 80 years, Neisseria gonorrhoeae has shown remarkable versatility in its ability to develop resistance to successive classes of drugs. As a result, national and international treatment guidelines have had to be regularly updated to take account of increases in the prevalence of gonococcal strains resistant to recommended antibiotics. Even when particular antibiotics are no longer empirically used to treat gonorrhoea, N. gonorrhoeae often retains resistance, with strains becoming MDR over time. Future efforts to ensure gonorrhoea remains a treatable infection will require a multidisciplinary global approach including efforts to provide widely available and affordable diagnostic testing, robust international surveillance of resistance, and the development of new antibiotics coupled with enhanced antimicrobial stewardship to ensure optimal use of both new and older antimicrobial agents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Neisseria gonorrhoeaeGonorrheaAnti-Bacterial AgentsDrug Resistance, BacterialDrug Resistance, Multiple, BacterialHumansAntimicrobial StewardshipGlobal Health

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Blood Safety, Hepatitis, STI & HIV Division, UK Health Security Agency, London NW9 5EQ, UK.
  • Journal of Antimicrobial Chemotherapy, Birmingham B1 3NJ, UK.

ORCID-Profile: Helen Fifer

Zitieren

APA

Fifer, H., & Johnson, A. (2025). The continuing evolution of antibiotic resistance in Neisseria gonorrhoeae : past, present and future threats to effective treatment. Journal of Antimicrobial Chemotherapy, 80(5), 1213-1219. https://doi.org/10.1093/jac/dkaf109

Vancouver

Fifer H, Johnson A. The continuing evolution of antibiotic resistance in Neisseria gonorrhoeae : past, present and future threats to effective treatment. Journal of Antimicrobial Chemotherapy. 2025;80(5):1213-1219. doi:10.1093/jac/dkaf109

BibTeX
@article{Fifer2025,
  author = {Fifer, Helen and Johnson, Alan},
  title = {The continuing evolution of antibiotic resistance in Neisseria gonorrhoeae : past, present and future threats to effective treatment},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2025},
  volume = {80},
  number = {5},
  pages = {1213--1219},
  doi = {10.1093/jac/dkaf109}
}
Kostenlos starten →